m+Medelevator.RU
← Поиск публикаций
Frontiers in neurology · 2025

The efficacy and safety of acupuncture for Parkinson's disease insomnia: a systematic review and meta-analysis.

СтатьяСистематический обзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Gu Yujie, Liang Yue, Han Hui, Yin Huichao, Zheng Zuncheng

Аннотация

BACKGROUND: Insomnia is a common comorbid symptom in Parkinson's disease (PD) patients, significantly impairing their quality of life. Acupuncture is widely applied in treating PD insomnia, yet relevant evidence remains fragmented.

OBJECTIVE: To investigate the efficacy of acupuncture in improving PD insomnia through systematic review and meta-analysis, evaluating its clinical effectiveness and safety.

METHODS: Eight electronic databases were searched: PubMed, Cochrane Library, Embase, Web of Science, China National Knowledge Infrastructure (CNKI), VIP Data Platform, Wanfang Data Knowledge Service Platform, and China Biomedical Literature Service System. References from relevant literature and clinical trial registries were manually searched for randomized controlled trials (RCTs) on acupuncture for PD insomnia. Studies were screened against inclusion and exclusion criteria, relevant data extracted, and meta-analysis conducted using RevMan 5.4 software.

RESULTS: Eleven studies involving 800 patients were included. Meta-analysis revealed that acupuncture effectively improved PSQI (MD = -2.87, 95% CI: -4.28 to -1.46, p < 0.0001) and PDSS (MD = 7.96, 95% CI: 5.55-10.37, p < 0.00001), demonstrating superior efficacy compared to the control group (MD = 6.64, 95% CI: 3.47-12.69, p < 0.00001).

CONCLUSION: Acupuncture effectively improves PSQI and PDSS scores in patients with PD insomnia and exhibits superior efficacy over the control group. However, due to limitations, further details could not be explored.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты